FHTX

Foghorn Therapeutics Inc.

Insider trading activity for Foghorn Therapeutics Inc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 6 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 12 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Transaction history

The 34 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Jun 24	Gallagher Neil	Director	AGRANT◆	28,000	$4.08	$114.2K	—	Open the original filing on SEC.gov
Jun 24	Mendelsohn Michael	Director	AGRANT◆	28,000	$4.08	$114.2K	—	Open the original filing on SEC.gov
Jun 24	Lynch Thomas J. Jr.	Director	AGRANT◆	28,000	$4.08	$114.2K	—	Open the original filing on SEC.gov
Jun 24	Smith Ian F	Director	AGRANT◆	28,000	$4.08	$114.2K	—	Open the original filing on SEC.gov
Jun 24	Gill Simba	Director	AGRANT◆	28,000	$4.08	$114.2K	—	Open the original filing on SEC.gov
Jun 24	Parshall B Lynne	Director	AGRANT◆	28,000	$4.08	$114.2K	—	Open the original filing on SEC.gov
Jun 24	Duty Stuart	Director	AGRANT◆	28,000	$4.08	$114.2K	—	Open the original filing on SEC.gov
Jun 24	Cole Douglas G.	Director	AGRANT◆	28,000	$4.08	$114.2K	—	Open the original filing on SEC.gov
Jun 24	Biller Scott	Director	AGRANT◆	28,000	$4.08	$114.2K	—	Open the original filing on SEC.gov
Apr 10	Gottschalk Adrian	Chief Executive Officer	GGIFT	59,208	—	—	+28.0%	Open the original filing on SEC.gov
Apr 10	Gottschalk Adrian	Chief Executive Officer	GGIFT	59,208	—	—	-19.7%	Open the original filing on SEC.gov
Apr 9	Gottschalk Adrian	Chief Executive Officer	GGIFT	47,497	—	—	+28.9%	Open the original filing on SEC.gov
Apr 9	Gottschalk Adrian	Chief Executive Officer	GGIFT	47,497	—	—	-100.0%	Open the original filing on SEC.gov
Feb 23	Maynard Ryan D	Chief Financial Officer	AGRANT◆	400,000	$5.75	$2.3M	—	Open the original filing on SEC.gov
Feb 5	Gottschalk Adrian	Chief Executive Officer	AGRANT◆	1.1M	$5.23	$5.6M	—	Open the original filing on SEC.gov
Jan 30	Rivkin Anna	Chief Business Officer	AGRANT◆	165,000	$5.71	$942.2K	—	Open the original filing on SEC.gov
Jan 30	LaCascia Michael	Chief Legal Officer	AGRANT◆	295,000	$5.71	$1.7M	—	Open the original filing on SEC.gov
Jan 30	Costa Carlos	Chief People Officer	AGRANT◆	230,000	$5.71	$1.3M	—	Open the original filing on SEC.gov
Jan 30	Cardama Alfonso Quintas	Chief Medical Officer	AGRANT◆	300,000	$5.71	$1.7M	—	Open the original filing on SEC.gov
Jan 30	Bellon Steven F.	Chief Scientific Officer	AGRANT◆	300,000	$5.71	$1.7M	—	Open the original filing on SEC.gov
Jan 13	Flagship Pioneering, LLC	Director, 10% Owner	AGRANT◆	1.1M	—	—	—	Open the original filing on SEC.gov
Jan 13	Flagship Pioneering, LLC	Director, 10% Owner	AGRANT◆	1.1M	—	—	—	Open the original filing on SEC.gov
Jan 13	Flagship Pioneering, LLC	Director, 10% Owner	AGRANT◆	2.2M	$6.71	$15M	—	Open the original filing on SEC.gov
Jun 17, 2025	Smith Ian F	Director	AGRANT◆	25,000	$4.79	$119.8K	—	Open the original filing on SEC.gov
Jun 17, 2025	Parshall B Lynne	Director	AGRANT◆	25,000	$4.79	$119.8K	—	Open the original filing on SEC.gov
Jun 17, 2025	Mendelsohn Michael	Director	AGRANT◆	25,000	$4.79	$119.8K	—	Open the original filing on SEC.gov
Jun 17, 2025	Lynch Thomas J. Jr.	Director	AGRANT◆	25,000	$4.79	$119.8K	—	Open the original filing on SEC.gov
Jun 17, 2025	Gill Simba	Director	AGRANT◆	25,000	$4.79	$119.8K	—	Open the original filing on SEC.gov
Jun 17, 2025	Cole Douglas G.	Director	AGRANT◆	25,000	$4.79	$119.8K	—	Open the original filing on SEC.gov
Jun 17, 2025	Biller Scott	Director	AGRANT◆	25,000	$4.79	$119.8K	—	Open the original filing on SEC.gov
May 1, 2025	Gallagher Neil	Director	AGRANT◆	50,000	$4.16	$208K	—	Open the original filing on SEC.gov
May 1, 2025	Duty Stuart	Director	AGRANT◆	50,000	$4.16	$208K	—	Open the original filing on SEC.gov
Apr 25, 2025	Gottschalk Adrian	Chief Executive Officer	GGIFT	300,000	—	—	+141.7%	Open the original filing on SEC.gov
Apr 25, 2025	Gottschalk Adrian	Chief Executive Officer	GGIFT	300,000	—	—	-37.0%	Open the original filing on SEC.gov

AGRANT◆$114.2K

Gallagher Neil · DirectorJun 24

28,000 sh @ $4.08

AGRANT◆$114.2K

Mendelsohn Michael · DirectorJun 24

28,000 sh @ $4.08

AGRANT◆$114.2K

Lynch Thomas J. Jr. · DirectorJun 24

28,000 sh @ $4.08

AGRANT◆$114.2K

Smith Ian F · DirectorJun 24

28,000 sh @ $4.08

AGRANT◆$114.2K

Gill Simba · DirectorJun 24

28,000 sh @ $4.08

AGRANT◆$114.2K

Parshall B Lynne · DirectorJun 24

28,000 sh @ $4.08

AGRANT◆$114.2K

Duty Stuart · DirectorJun 24

28,000 sh @ $4.08

AGRANT◆$114.2K

Cole Douglas G. · DirectorJun 24

28,000 sh @ $4.08

AGRANT◆$114.2K

Biller Scott · DirectorJun 24

28,000 sh @ $4.08

GGIFT—

Gottschalk Adrian · Chief Executive…Apr 10

59,208 sh · +28.0% own

GGIFT—

Gottschalk Adrian · Chief Executive…Apr 10

59,208 sh · -19.7% own

GGIFT—

Gottschalk Adrian · Chief Executive…Apr 9

47,497 sh · +28.9% own

GGIFT—

Gottschalk Adrian · Chief Executive…Apr 9

47,497 sh · -100.0% own

AGRANT◆$2.3M

Maynard Ryan D · Chief Financial…Feb 23

400,000 sh @ $5.75

AGRANT◆$5.6M

Gottschalk Adrian · Chief Executive…Feb 5

1.1M sh @ $5.23

AGRANT◆$942.2K

Rivkin Anna · Chief Business…Jan 30

165,000 sh @ $5.71

AGRANT◆$1.7M

LaCascia Michael · Chief Legal…Jan 30

295,000 sh @ $5.71

AGRANT◆$1.3M

Costa Carlos · Chief People…Jan 30

230,000 sh @ $5.71

AGRANT◆$1.7M

Cardama Alfonso Quintas · Chief Medical…Jan 30

300,000 sh @ $5.71

AGRANT◆$1.7M

Bellon Steven F. · Chief Scientific…Jan 30

300,000 sh @ $5.71

AGRANT◆—

Flagship Pioneering, LLC · Director, 10%…Jan 13

1.1M sh

AGRANT◆—

Flagship Pioneering, LLC · Director, 10%…Jan 13

1.1M sh

AGRANT◆$15M

Flagship Pioneering, LLC · Director, 10%…Jan 13

2.2M sh @ $6.71

AGRANT◆$119.8K

Smith Ian F · DirectorJun 17, 2025

25,000 sh @ $4.79

AGRANT◆$119.8K

Parshall B Lynne · DirectorJun 17, 2025

25,000 sh @ $4.79

AGRANT◆$119.8K

Mendelsohn Michael · DirectorJun 17, 2025

25,000 sh @ $4.79

AGRANT◆$119.8K

Lynch Thomas J. Jr. · DirectorJun 17, 2025

25,000 sh @ $4.79

AGRANT◆$119.8K

Gill Simba · DirectorJun 17, 2025

25,000 sh @ $4.79

AGRANT◆$119.8K

Cole Douglas G. · DirectorJun 17, 2025

25,000 sh @ $4.79

AGRANT◆$119.8K

Biller Scott · DirectorJun 17, 2025

25,000 sh @ $4.79

AGRANT◆$208K

Gallagher Neil · DirectorMay 1, 2025

50,000 sh @ $4.16

AGRANT◆$208K

Duty Stuart · DirectorMay 1, 2025

50,000 sh @ $4.16

GGIFT—

Gottschalk Adrian · Chief Executive…Apr 25, 2025

300,000 sh · +141.7% own

GGIFT—

Gottschalk Adrian · Chief Executive…Apr 25, 2025

300,000 sh · -37.0% own

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

All 21 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →